In this CE Concepts live symposium, expert faculty will review the latest clinical evidence for integrating FRα testing into treatment decision-making as well as practical strategies for selecting and sequencing FRα-targeted ADCs, including anticipating and managing toxicities, to deliver personalized, multidisciplinary care with greater confidence in the rapidly evolving PROC treatment landscape.